Celadon Pharmaceuticals Plc (AIM:CEL)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3.844
-2.276 (-37.19%)
Apr 1, 2025, 10:01 AM GMT+1

Celadon Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2020 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Aug '20 2019
Market Capitalization
47431---
Upgrade
Market Cap Growth
-43.27%137.10%----
Upgrade
Enterprise Value
97726---
Upgrade
Last Close Price
0.061.150.51---
Upgrade
PS Ratio
29.84984.541297.64---
Upgrade
PB Ratio
1.6323.214.43---
Upgrade
P/TBV Ratio
24.2226.094.30---
Upgrade
EV/Sales Ratio
69.231025.361091.22---
Upgrade
Debt / Equity Ratio
1.951.480.66-2.7129.52-
Upgrade
Asset Turnover
0.020.010.000--
Upgrade
Inventory Turnover
0.391.238.18---
Upgrade
Quick Ratio
1.002.205.120.460.54131.57
Upgrade
Current Ratio
1.922.625.290.480.88131.79
Upgrade
Return on Equity (ROE)
-190.70%-142.14%-1318.52%---
Upgrade
Return on Assets (ROA)
-34.40%-34.58%-73.35%-26.89%-14.21%-
Upgrade
Return on Capital (ROIC)
-41.33%-39.71%-84.13%-32.15%-16.54%-
Upgrade
Earnings Yield
-124.18%-9.67%-54.61%---
Upgrade
FCF Yield
-136.33%-8.55%-26.28%---
Upgrade
Buyback Yield / Dilution
-2.70%-8.03%-29.26%-143913.21%99.50%-
Upgrade
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.